Three High Profile Publications Support the Potential of Protagenic Therapeutics’s Synthetic TCAP to Treat Stress-Related Psychological Disorders
June 11, 2018 10:15 ET
|
Protagenic Therapeutics, Inc.
Ancient, central role of brain peptide TCAP in maintenance of brain health elucidated in publications in Cell, Nature Communications, and the Journal of Neuro-endocrinology NEW YORK,...
Protagenic’s Neuropeptide Shows Strong Efficacy in Treating Depression and Anxiety of Established Rodent Models
September 28, 2017 09:07 ET
|
Protagenic Therapeutics, Inc.
First in class psychotropic agent50% reduction in anxiety related symptomsData generated by independent world-renowned laboratory NEW YORK, Sept. 28, 2017 (GLOBE NEWSWIRE) -- Protagenic...